This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on May 20, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI to Sole Source to Central Admixture Services, Inc.
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center intends to award a one-year, firm-fixed-price contract solely to Central Admixture Pharmacy Services, Inc. for the procurement of compounded sterile products including patient-specific parenteral nutrition, renal replacement therapy, and select non-patient-specific sterile compounds essential for patient care. This acquisition is justified under FAR 6.302-1 as a sole-source requirement because CAPS, Inc. is the original manufacturer with no other authorized distributors in the U.S. capable of meeting the required standards, and no other sources are reasonably available. The contract will be executed under Simplified Acquisition Procedures per FAR Part 13.106-1(b)(1), exempting it from full and open competition requirements. The performance location is the NIH Clinical Center in Bethesda, Maryland, with an anticipated start date in June 2026, and the Product Service Code is 6515 under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The contract is not subject to any small business or other set-asides, and no competitive evaluation factors will be applied. Comments regarding the sole-source determination must be submitted by May 26, 2026, to Huda Malik, Contract Specialist, via email. Key administrative points of contact include the Contracting Officer’s Representative, Fortin Georges, and his supervisor Saly Gabriel of the Pharmacy Department. Although the estimated contract value is not specified, the award is contingent on the Contracting Officer’s determination that the price will be fair and reasonable. No detailed deliverables, packaging, inspection protocols, or invoicing terms are included in the notice, as this document serves solely as a presolicitation notice and justification for non-competitive procurement.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The purpose of this acquisition is to contract with a source for select non-patient-specific sterile compounded products and patient specific parenteral nutrition and renal replacement therapy that meet the quality expectations to provide to National Institutes of Health Clinical Center (NIH CC) patients on an ongoing basis.
• Product Service Code: 6515 – Medical and Surgical Instruments, Equipment, and Supplies
• NAICS Code: 325412 – Pharmaceutical Preparation Manufacturing
• Place of Performance: NIH Clinical Center, Bethesda, MD 20892 USA
POTS: 26-000037
Description:
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health (NIH) intends to award a one-year contract to Central Admixture Pharmacy Services, Inc. (CAPS, Inc.), located at PO. BOX 780404, Philadelphia, PA 19178, on a firm fixed price sole source award basis for the purchase of compounded TPN and other compounded products for patient care.
The proposed vendor, CAPS Inc., is the Original Manufacturer and has not designated other distributors for compounded products in the U.S.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Huda Malik, Contract Specialist via email to huda.malik@nih.gov by May 26, 2026 by 3 pm EST.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS